Sildamax is an oral tablet taken by mouth for the treatment of erectile dysfunction in adult men. It supports the vascular response needed for an erection during sexual stimulation, with the dose…
Sildamax is an oral tablet taken by mouth for the treatment of erectile dysfunction in adult men. It supports the vascular response needed for an erection during sexual stimulation, with the dose selected according to individual response, health status, and concurrent medicines.
Sildamax belongs to the PDE5-inhibitor category used in erectile dysfunction treatment. PDE5 means phosphodiesterase type 5, an enzyme involved in regulating blood flow in erectile tissue. The product is supplied as tablets, and the strength marking is 100.
The tablet is intended for adult male use. It does not create sexual desire and does not produce an erection without sexual stimulation. Its role is to support the physical blood-flow response when arousal is already present.
The 100 strength represents a higher sildenafil-type PDE5-inhibitor strength used in some treatment plans. It is not automatically the correct starting strength for every man. Age, cardiovascular health, kidney function, liver function, other medicines, and previous tolerability all influence dose selection.
The European Medicines Agency and HPRA describe PDE5 inhibitors as medicines that enhance the nitric-oxide pathway involved in penile erection. Product information for this class also places firm limits on frequency of use and warns against specific cardiovascular combinations [1].
Sildamax belongs to the PDE5-inhibitor category used in erectile dysfunction treatment. PDE5 means phosphodiesterase type 5, an enzyme involved in regulating blood flow in erectile tissue. The product is supplied as tablets, and the strength marking is 100.
The tablet is intended for adult male use. It does not create sexual desire and does not produce an erection without sexual stimulation. Its role is to support the physical blood-flow response when arousal is already present.
The 100 strength represents a higher sildenafil-type PDE5-inhibitor strength used in some treatment plans. It is not automatically the correct starting strength for every man. Age, cardiovascular health, kidney function, liver function, other medicines, and previous tolerability all influence dose selection.
The European Medicines Agency and HPRA describe PDE5 inhibitors as medicines that enhance the nitric-oxide pathway involved in penile erection. Product information for this class also places firm limits on frequency of use and warns against specific cardiovascular combinations [1].
Sildamax is intended for adult men with erectile dysfunction. It supports the blood-flow response needed for an erection during sexual stimulation, but it does not create sexual desire or produce an erection without arousal.
Sildenafil-type PDE5 inhibitors are commonly taken before planned sexual activity. Clinical product information describes an onset that often occurs within 30–60 minutes, with timing affected by food, age, metabolism, and individual response. A large or fatty meal can delay absorption.
The effect is temporary. It does not mean that an erection should last for several hours continuously. An erection lasting four hours or longer is an emergency because prolonged rigidity can damage erectile tissue; immediate emergency care is required.
The appropriate dose differs between strengths and between users, so there is no single amount that suits everyone. A 100-strength tablet should be used only when that strength has been selected for the individual treatment plan.
Practical administration points include:
The tablet should not be crushed or altered unless a prescriber or pharmacist has specifically directed this. Altering a tablet can make administration less predictable.
Men using alpha-blockers for urinary symptoms or blood pressure may experience a greater fall in blood pressure when a PDE5 inhibitor is added. This combination needs individual dose planning, especially when dizziness or fainting has occurred before.
Sildamax is not suitable for every man. The most important contraindication is concurrent use of organic nitrates, including nitrate medicines used for angina. The combination can cause a dangerous fall in blood pressure. Recreational nitrite products can create the same concern.
The HPRA and EMA also identify caution with alpha-blockers, blood-pressure medicines, strong CYP3A4 inhibitors, and medicines used for HIV treatment. Kidney or liver impairment may increase exposure and can require a lower starting dose. The product should not be combined with another PDE5 inhibitor.
This treatment may not be suitable if you use nitrate medicines for chest pain or recreational nitrites such as “poppers”. Men with unstable heart disease, recent heart attack or stroke, severe blood-pressure problems, or a previous serious allergic reaction to this type of medicine should not use it without medical clearance. Tell a clinician about alpha-blockers, blood-pressure medicines, HIV treatment, kidney or liver problems, and any sudden vision loss linked to a previous eye condition.
Alcohol can worsen dizziness, reduce blood pressure, and make erectile function less reliable. It may also make it harder to judge whether a side effect comes from the medicine or intoxication.
Pregnancy is not a routine indication for this product. Men who take medicines that affect blood pressure, clotting, heart rhythm, or liver metabolism require a specific interaction review before use.
Common reactions associated with sildenafil-type PDE5 inhibitors include headache, facial flushing, indigestion, nasal congestion, dizziness, and visual changes. These effects are usually related to blood-vessel relaxation or the medicine’s action on related phosphodiesterase enzymes. The FDA prescribing information describes dose-related adverse reactions and advises prompt assessment of serious symptoms [1].
Visual effects may include a blue tinge, increased brightness, or blurred vision. A mild, short-lived change differs from sudden loss of vision, which requires urgent medical attention. Sudden hearing loss, severe chest pain, fainting, or a serious allergic reaction also require urgent care.
Possible adverse effects include:
A common practical mistake is taking another tablet because flushing or headache is mistaken for treatment failure. That can increase exposure without improving the erection. Rest, hydration, and avoiding excess alcohol may reduce dizziness, though they do not remove the medicine’s interaction risks.
One detail patients often miss is the difference between mild visual colour change and a dangerous visual event. Sudden or persistent visual loss is not a routine nuisance effect.
Sexual stimulation causes nerves in the penis to release nitric oxide. Nitric oxide activates an enzyme that increases cyclic guanosine monophosphate, usually called cyclic GMP. This messenger relaxes smooth muscle in the corpus cavernosum, the paired erectile tissues inside the penis.
PDE5 breaks down cyclic GMP. A PDE5 inhibitor slows that breakdown, allowing the relaxation signal to last longer. Blood can then enter the corpus cavernosum more readily, supporting erection development and maintenance.
The medicine does not permanently widen the penile blood vessels. Its effect depends on the normal sexual-response pathway, adequate arousal, and sufficient blood flow. Anxiety, low testosterone, diabetes, vascular disease, pelvic surgery, and relationship factors can still affect the result.
The process can be understood in four stages:
Sildamax is therefore a response-supporting treatment rather than an aphrodisiac. It cannot correct every cause of erectile dysfunction, and repeated treatment failure deserves clinical assessment for diabetes, hypertension, cardiovascular disease, hormonal problems, or medication-related sexual dysfunction.
Several avoidable errors reduce benefit or increase risk:
A blue or blurred visual effect should not be concealed if it recurs. The symptom may be temporary, but repeated episodes need clinical assessment.
Treatment choices differ mainly by active substance, onset pattern, duration, interactions, and the patient’s medical history. A prescriber may choose a shorter-acting PDE5 inhibitor for planned use or a longer-acting option when a wider time window is preferred.
| Treatment category | Main practical feature | Main limitation |
|---|---|---|
| Sildenafil-type PDE5 inhibitor | Familiar pre-planned treatment with a moderate duration | Food may delay the response; headache and flushing can occur |
| Tadalafil-type PDE5 inhibitor | Longer response window for some patients | Back pain, indigestion, and prolonged interaction potential may occur |
| Vardenafil-type PDE5 inhibitor | Similar PDE5 mechanism with individual response differences | Cardiovascular and medicine-interaction screening remains necessary |
All PDE5 inhibitors share important safety restrictions. They must not be combined with organic nitrates, and they are unsuitable for some men with unstable cardiovascular disease. Switching between PDE5 inhibitors without allowing for the previous medicine’s effect can increase adverse reactions.
Treatments containing dapoxetine belong to a different pharmacological approach and are used for premature ejaculation rather than erectile dysfunction alone. They should not be added to a PDE5 inhibitor without a clinician assessing the combination.
In clinical practice, doctors usually assess erectile dysfunction as a possible vascular symptom rather than treating it as an isolated bedroom problem. Erectile difficulties can appear before other signs of hypertension, diabetes, or cardiovascular disease. A treatment response can be useful, but it does not remove the need to address those underlying risks. Cardiovascular risk assessment can therefore form part of an erectile dysfunction review. The findings may also guide treatment of diabetes, hypertension, or other contributing conditions.
A physician would also ask about nitrate use, alpha-blockers, recent cardiovascular events, stroke, eye disease, kidney function, liver function, and previous reactions to PDE5 inhibitors. The 100 strength may be appropriate for some men and excessive for others. Dose escalation should follow tolerability, not impatience.
Patients sometimes report that the medicine worked on one occasion but not another. Meal timing, anxiety, inadequate stimulation, alcohol, and the cause of the erectile dysfunction can explain this variation. Treatment failure after several correctly timed attempts should prompt a review rather than repeated self-escalation.
Dizziness, visual changes, blurred vision, or a fall in blood pressure can make driving and machinery work unsafe. The FDA prescribing information reviewed in 2014 advises caution until an individual knows how the medicine affects vision and alertness . Avoid driving if you feel light-headed, see colour changes, or have blurred vision, and do not drive after an adverse reaction has begun.
Sildamax is intended for erectile dysfunction in adult men and is not a routine medicine for pregnancy or breastfeeding. The EMA sildenafil Summary of Product Characteristics reviewed in 2023 does not support ordinary use of this treatment for pregnant or breastfeeding patients. A partner’s use does not expose a pregnancy through semen in the way maternal medicine use exposes a fetus, but the tablet should still be used only by the person for whom it was selected.
Older adults may use PDE5-inhibitor treatment when their cardiovascular health, kidney function, liver function, and other medicines have been reviewed. The HPRA sildenafil product information updated in 2024 highlights the need to consider alpha-blockers, antihypertensives, and medicines that alter sildenafil metabolism. Age alone does not automatically rule out treatment, though a lower starting exposure may be chosen when clearance is reduced.
Use with organic nitrates for angina is a clear contraindication because the combination can cause severe hypotension. The FDA label from 2014 also warns against use when sexual activity is unsafe because of unstable cardiovascular disease . A history of nitrate use, recent major cardiovascular events, or unexplained chest pain requires medical review before any PDE5-inhibitor tablet is considered.
Sildamax is generally used when needed rather than as a fixed daily course, with no more than one dose in 24 hours. The WHO guideline on self-care interventions for health and well-being, published in 2019, supports reviewing repeated treatment according to benefit, tolerability, cardiovascular status, and interactions. Long-term use may be acceptable for some men when periodic clinical review confirms that the treatment remains appropriate and no new contraindication has developed.
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.
Based on 4 reviews
I used the tablet before a planned evening and noticed a response after roughly 45 minutes. The first time I had a headache and a flushed face, so I did not repeat the dose. On later use, taking it after a lighter meal felt more predictable.
15 Oct 2026The tablet helped with firmness, but it did not improve desire or anxiety. I had expected a stronger effect straight away. After cutting back on alcohol and allowing more time for stimulation, the result was better, although the nasal congestion was irritating.
24 Oct 2026I tried it twice over two weeks. The first attempt seemed weak after a heavy dinner, while the second worked better before food. I experienced mild indigestion but no vision problems, and the timing became easier to judge.
Two weeks 29 Oct 2026I stopped after dizziness during the first use. I was also taking medicine for blood pressure, so I arranged a review rather than trying another tablet. The response itself was present, but the light-headedness made the treatment unsuitable for me at that time.
12 Nov 2026
